AVAX ONE TECHNOLOGY LTD.
Common Shares
Preferred Shares
Warrants
Units
We may, from time to time, in one or more offerings at prices and on terms that we will determine at the time of each offering, sell common shares, preferred shares, warrants, units or a combination of these securities for an aggregate initial offering price of up to $2,000,000,000. This prospectus provides you with a general description of the securities we may offer, which is not meant to be a complete description of each of the securities. Each time we offer and sell securities, we will provide one or more prospectus supplements that will contain specific information about the terms of that offering. We may also authorize one or more free writing prospectuses to be provided to you in connection with an offering. Any prospectus supplement or free writing prospectus may also add, update, or change information contained in this prospectus. You should carefully read this prospectus, the applicable prospectus supplement and any related free writing prospectus, as well as the documents incorporated or deemed to be incorporated by reference, before you purchase any of the securities offered.
This prospectus may not be used to offer and sell securities unless accompanied by a prospectus supplement.
Our common shares are currently traded on the Nasdaq Capital Market under the symbol "AVX." On December 4, 2025, the last reported sales price for our common shares was $2.04 per share. The prospectus supplement will contain information, where applicable, as to any other listing, if any, on the Nasdaq Capital Market or any other securities market or exchange of the securities covered by the applicable prospectus supplement.
In addition, these securities also may be resold by selling securityholders. Selling securityholders may offer and sell, from time to time, these securities on terms described in a prospectus supplement.
This prospectus describes some of the general terms that may apply to these securities. The specific terms of any securities to be offered will be described in a prospectus supplement. The prospectus supplement may also add, update or change information contained in this prospectus. You should read this prospectus and the applicable prospectus supplement carefully before you make your investment decision.
We and/or the selling securityholders may offer and sell these securities to or through one or more underwriters, dealers and agents, or directly to purchasers, on a continuous or delayed basis.
We may offer the securities directly or through agents or to or through underwriters or dealers. If any agents or underwriters are involved in the sale of the securities, their names, and any applicable purchase price, fee, commission or discount arrangement between or among them, will be set forth, or will be calculable from the information set forth, in an accompanying prospectus supplement. We can sell the securities through agents, underwriters or dealers only with delivery of a prospectus supplement describing the method and terms of the offering of such securities. See "Plan of Distribution" section of this prospectus for further information.